NDC 63539-436

CIBINQO

Abrocitinib

CIBINQO is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by U.s. Pharmaceuticals. The primary component is Abrocitinib.

• Product ID: 63539-436_e12a1371-0adf-4237-a624-1bc713f5247c
• NDC: 63539-436
• Product Type: Human Prescription Drug
• Proprietary Name: CIBINQO
• Generic Name: Abrocitinib
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2022-02-24
• Marketing Category: NDA /
• Application Number: NDA213871
• Labeler Name: U.S. Pharmaceuticals
• Substance Name: ABROCITINIB
• Active Ingredient Strength: 200 mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 63539-436-14

14 TABLET, FILM COATED in 1 BOTTLE (63539-436-14)

• Marketing Start Date: 2022-02-24
• NDC Exclude Flag: N
• Sample Package?: Y

Drug Details

NDC Crossover Matching brand name "CIBINQO" or generic name "Abrocitinib"

NDC	Brand Name	Generic Name
0069-0235	Cibinqo	abrocitinib
0069-0335	Cibinqo	abrocitinib
0069-0435	Cibinqo	abrocitinib
63539-236	CIBINQO	abrocitinib
63539-336	CIBINQO	abrocitinib
63539-436	CIBINQO	abrocitinib